Observational studyThe pharmacogenomics journal2017

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

F S Falvella et al.PubMed ↗Publisher ↗

No numbers read from the abstract.